跳至主要内容
临床试验/NCT01615731
NCT01615731已完成不适用

Value of Mifepristone in Eliminating the Need for a Second Set of Osmotic Dilators Prior to Dilation and Evacuation Between 19-24 Weeks: A Randomized Trial

Stanford University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Total Procedure Time

研究概览

简要总结

A common practice for preparation for surgical abortion after 19 weeks gestation is the placement of multiple sets of osmostic dilators 1-2 days prior to the procedure. The investigators aim to study the addition of mifepristone as an adjunct to cervical dilation prior to abortion between 19-24 weeks gestation, and its potential to minimize the number of painful procedures and time in clinic (or away from work/home) that multiple sets of dilators can require. The investigators hypothesize that one set of dilators with mifepristone will result in similar procedure times and decreased "total" time as two sets of dilators.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • >18 years old
  • Viable, Singleton pregnancy
  • Voluntarily seeking abortion between 19 and 24wks gestation
  • Able to give informed consent and comply with study protocol
  • Fluent in English or Spanish

排除标准

  • Allergy to misoprostol or mifepristone

研究组 & 干预措施

Two sets of dilators

Active Comparator

Two sets of osmotic dilators inserted 1 and 2 days pre-op

干预措施: Hygroscopic cervical dilators (Other)

Two sets of dilators

Active Comparator

Two sets of osmotic dilators inserted 1 and 2 days pre-op

干预措施: Misoprostol (Drug)

Two sets of dilators

Active Comparator

Two sets of osmotic dilators inserted 1 and 2 days pre-op

干预措施: Intra-amniotic digoxin (Drug)

Mifepristone plus one set of dilators

Experimental

One set of dilators plus mifepristone

干预措施: Mifepristone (Drug)

Mifepristone plus one set of dilators

Experimental

One set of dilators plus mifepristone

干预措施: Hygroscopic cervical dilators (Other)

Mifepristone plus one set of dilators

Experimental

One set of dilators plus mifepristone

干预措施: Misoprostol (Drug)

Mifepristone plus one set of dilators

Experimental

One set of dilators plus mifepristone

干预措施: Intra-amniotic digoxin (Drug)

结局指标

主要结局

Total Procedure Time

时间窗: Measured at clinic visits and on OR day, over a 3 day period

Procedure Time

时间窗: Intraoperative Time

Measured as time from speculum insertion to removal

次要结局

  • Adverse Events (EBL)(Intraoperatively)
  • Overall Patient Experience(Measured post operatively (at least 30 minutes, on average 1.5 hours) prior to discharge)
  • Ease of Procedure by Blinded Surgeon(Measured Immediately after procedure)
  • Maximum Cervical Dilation(Measured intra-operatively)
  • Pain Perceived by Patient(Measured pre-operatively (after misoprostol, immediately before transport to OR) and post-operatively (in recovery room, on average 1.5 hours post-operatively))
  • Adverse Events(Intraoperatively and 2 weeks post operatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验